Figure 4
From: Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
CLU2 expression in the TIR3 FNAB samples classified according to the histopathological diagnosis. (A) CLU2 expression was compared to CLU1, arbitrarily setted as 100%. (B) ROC curve analysis showed the usefulness of the ratio of CLU2:CLU1 expression for clearly distinguishing the malignant thyorid tumors from adenoma in patients with TIR3 thyorid FNAB lesions. MedCalc statistical software was used for statistical analysis.